These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8987133)

  • 1. Design of controlled clinical trials for diabetic polyneuropathy.
    Sima AA; Laudadio C
    Semin Neurol; 1996 Jun; 16(2):187-91. PubMed ID: 8987133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies.
    Adriaensen H; Plaghki L; Mathieu C; Joffroy A; Vissers K
    Diabetes Metab Res Rev; 2005; 21(3):231-40. PubMed ID: 15858788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study.
    Atli A; Dogra S
    Pain Med; 2005; 6(3):225-34. PubMed ID: 15972086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings].
    Hansen LJ; Drivsholm TB
    Ugeskr Laeger; 2002 Jan; 164(5):607-9. PubMed ID: 11871208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic polyneuropathy in controlled clinical trials: Consensus Report of the Peripheral Nerve Society.
    Ann Neurol; 1995 Sep; 38(3):478-82. PubMed ID: 7668839
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
    Foster TS
    Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.
    Nicolucci A; Carinci F; Cavaliere D; Scorpiglione N; Belfiglio M; Labbrozzi D; Mari E; Benedetti MM; Tognoni G; Liberati A
    Diabet Med; 1996 Dec; 13(12):1017-26. PubMed ID: 8973882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
    Vereşiu IA
    Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug prescriptions and costs in diabetic polyneuropathy].
    Rathmann W; Haastert B; Giani G
    Dtsch Med Wochenschr; 1999 Jun; 124(22):681-6. PubMed ID: 10394347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ
    Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
    Woolley SB; Cardoni AA; Goethe JW
    Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials in dental primary care: what research methods have been used to produce reliable evidence?
    Crawford F
    Br Dent J; 2005 Aug; 199(3):155-60; discussion 152; quiz 174. PubMed ID: 16192958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis alongside clinical trials: problems and potential.
    Drummond M
    J Rheumatol; 1995 Jul; 22(7):1403-7. PubMed ID: 7562785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are better endpoints and better design of clinical trials needed?
    Fransen J; van Riel PL
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):97-109. PubMed ID: 15123040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for controlled trials of drugs in cluster headache.
    Lipton RB; Micieli G; Russell D; Solomon S; Tfelt-Hansen P; Waldenlind E
    Cephalalgia; 1995 Dec; 15(6):452-62. PubMed ID: 8706107
    [No Abstract]   [Full Text] [Related]  

  • 19. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
    Stracke H; Gaus W; Achenbach U; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):600-5. PubMed ID: 18473286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.